Insulin aspart, recombinant Subcutaneous and Zofran ODT
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zofran ODT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zofran ODT Oral, Oromucosal
- Insulin aspart, recombinant Subcutaneous-Zofran Oral, Oromucosal
- Insulin aspart, recombinant Subcutaneous-Zohydro ER
- Insulin aspart, recombinant Subcutaneous-Zohydro ER Capsules
- Insulin aspart, recombinant Subcutaneous-Zoladex
- Insulin aspart, recombinant Subcutaneous-Zoladex (Goserelin Implant 10.8 mg)
- Zofran ODT-Insulin degludec
- Zofran ODT-Insulin Degludec (U-100) Prefilled Pens
- Zofran ODT-Insulin Degludec (U-100) Vials
- Zofran ODT-Insulin Degludec (U-200) Prefilled Pens
- Zofran ODT-Insulin degludec and liraglutide
- Zofran ODT-Insulin degludec and liraglutide Subcutaneous